Mélanie Thill-Tayara

Dechert (Paris)
Lawyer (Partner)

Mélanie Thill-Tayara is partner at Dechert LLP in Paris. She is a competition lawyer based in Paris where she heads the French and European competition law department. She specialises in a variety of sectors including consumer goods, pharmaceuticals and medical devices, chemicals, leisure and luxury goods. Mélanie focuses on various aspects of EU and French competition law. She has acquired a strong reputation as a litigator and has been involved in landmark cases, for example in the field of essential facilities, dominance abuses in the pharma sector and information exchange systems. Melanie has represented major French and international companies in merger notifications before French and EU competition authorities, as well as in multi-jurisdictional filings. Mélanie is a member of the International Bar Association, the Association Française de l’Etude de la Concurrence and the Studienvereinigung Kartellrecht. She is a member of the board and executive committee of the Association des Avocats Pratiquant le Droit de la Concurrence (APDC). Mélanie regularly contributes to legal reviews as well as the legal pages of the financial and economic press. She is also a regular speaker at various competition law or sector-specialised conferences. Before joining Dechert, Mélanie spent 20 years as partner of another leading international law firm. Prior to that she worked for the European Commission, at the Directorate General for Competition for three years, during which she acted in historic cases such as the cement cartels. Mélanie holds a DEA (post-graduate degree) in business law and private international law from the University of Paris I Panthéon-Sorbonne, a Maîtrise (master’s degree) in International and European law, a Diploma from the Centre Universitaire d’Etudes Communautaires and a Diploma of Political Sciences from the University of Munich. She was admitted to the Paris Bar in 1987.

Distinctions

Linked authors

ESSEC Business School (Cergy)
Kramer Levin Naftalis & Frankel (Paris)
University Paris II Panthéon‑Assas
Ministère de la Justice (Paris)
Norton Rose Fulbright (Paris)
French State Council (Paris)
UK Competition Appeal Tribunal (London)
European Commission

Videos

Mélanie Thill-Tayara (Dechert)
Mélanie Thill-Tayara 30 November 2018 Paris
Mélanie Thill-Tayara (Dechert)
Mélanie Thill-Tayara 30 November 2018 Paris
Mélanie Thill-Tayara - Global Merger Control Conference - 2 December 2016
Mélanie Thill-Tayara 2 December 2016 Paris

Articles

808 Bulletin

Marion Provost, Mélanie Thill-Tayara Dominance in the pharmaceutical sector: An overview of EU and national case law

601

The pharmaceutical sector stands out as being regularly on the radar of competition authorities throughout Europe, with no less than 7 decisions adopted within the last 18 months and multiple on-going investigations, covering a wide range of practices, from excessive pricing to pay for delay, refusal to supply and, more generally, commercial strategies implemented by pharmaceutical companies to delay generic or biosimilar entry.

1756 Review

Mélanie Thill-Tayara, Stanislas Martin Stanislas MARTIN, French Competition Authority: Which balance between the effectiveness of competition procedures and the rights of defense?

354

Interview réalisée par Mélanie Thill-Tayara, Associée, Dechert, Paris. Diplômé de l’Institut d’études politiques de Paris et de l’ENA, vous avez occupé plusieurs postes au sein de la DGCCRF, travaillé pour la Représentation permanente de la France auprès de l’Union européenne et, moins classique, avez (...)

Andreas Mundt, Bruno Lasserre, Mélanie Thill-Tayara, Peter Freeman, Wouter Wils European Competition Network: 10 years after & EC Regulation 1/2003: Can cooperation be extended to merger control and advocacy? (New Frontiers of Antitrust, Paris, 21 February 2014)

567

This third roundtable of the conference “New frontiers of Antitrust” (Paris, 21 February 2014) was dedicated to “European Competition Network 10 years after & EC Regulation 1/2003: Can cooperation be extended to merger control and advocacy?”. The objectives for the authors of this roundtable (...)

Send a message